FIELD: pharmacology.
SUBSTANCE: invention is an antibacterial composition comprising lysostaphin in an amount of 1 to 1000 mcg/ml, high molecular weight chitosan, with a molecular weight in the range of 100 to 600 kDa in an amount of 10% to the lysostaphin weight used in the composition, a thickener selected from: polyvinyl alcohol in an amount of 2 to 15 wt %, or glycerol in an amount of 10 to 90 wt %, or polyethylene glycol in an amount of 1 to 20 wt %, or polyvinylpyrrolidone in an amount of 10 to 50 wt % and water - the rest.
EFFECT: invention provides high antibacterial activity against Staphylococcus aureus.
5 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING BACTERIAL ANTIGENS | 2018 |
|
RU2689161C1 |
| METHOD FOR PRODUCING STAPHYLOCOCCUS AUREUS ANTIGENS USING LYSOZYME AND LOW-MOLECULAR CHITOSAN | 2020 |
|
RU2740366C1 |
| ANTIBACTERIAL COMPOSITION CONTAINING WATER-SOLUBLE LOW-MOLECULAR CHITOSAN | 2012 |
|
RU2494746C1 |
| METHOD FOR EXPRESS-DETECTION OF ANTIBACTERIAL POTENTIAL OF CHITOSAN IN RESPECT TO STAPHYLOCOCCI | 2012 |
|
RU2488116C1 |
| HYDROGEL BASED ON CHITOSAN COMPLEX SALT AND METHOD OF ITS PREPARATION | 2015 |
|
RU2617501C1 |
| CATIONIC ANTISEPTIC BASED ON COMPOSITIONS OF L-B-MERCAPTOALANINE-SILVER SOLUTION AND NUTRITIVE CHITOSAN | 2014 |
|
RU2562113C1 |
| STAPHYLOCOCCUS EPIDERMIDIS BVM-1987 STRAIN - PRODUCER OF STAPHYLOLYTIC ENZYMIC COMPLEX | 2008 |
|
RU2403283C2 |
| STRAIN OF HYBRID CULTURED ANIMAL CELLS Mus musculus 2F9-PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC FOR LYSOSTAPHIN AND INHIBITING ITS LYTIC ACTIVITY | 2013 |
|
RU2525663C1 |
| TOOTH PASTE CONTAINING COMPLEX OF HYDROLASES | 2013 |
|
RU2527692C1 |
| TOOTH PASTE CONTAINING BUFFER MIXTURE | 2013 |
|
RU2527691C1 |
